Encorafenib | Marketing Authorisations | MA | Europe | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Encorafenib
Europe

EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

Contact Supplier

Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

Contact Supplier

Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

Contact Supplier

Inke S.A: APIs manufacturing plant.

Contact Supplier

Alchem offers Botanical APIs for Pharmaceuticals, Cosmetics and Nutraceuticals// FDA-inspected and EU-GMP certified.

Contact Supplier

Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

Contact Supplier

Encorafenib

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

10 API Suppliers, 3 USDMF, 1 EU WC, 4 NDC API, 6 Listed Suppliers, $ API Reference Price

10 API Suppliers
3 USDMF
1 EU WC
4 NDC API
6 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

90 Drugs in Development

90 Drugs in Development

INTERMEDIATES

4 Intermediate Suppliers

4 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

15 FDF Dossiers, 2 FDA Orange Book, 6 Europe, 1 Canada, 6 Australia

15 FDF Dossiers
2 FDA Orange Book
6 Europe
1 Canada
6 Australia

DIGITAL CONTENT

55 News #PharmaBuzz

55 News #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 9 Annual Reports

1 US Medicaid Prescriptions
9 Annual Reports

MARKET PLACE

2 APIs, 3 FDF Dossiers

2 APIs
3 FDF Dossiers

PATENTS & EXCLUSIVITIES

41 US Patents, 8 US Exclusivities, 5 Health Canada Patents

41 US Patents
8 US Exclusivities
5 Health Canada Patents

$ API Ref.Price (USD/KG) : 22,998 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

6 All

01 4Pierre Fabre Medicament

02 2Pierre Fabre Pharma Sa

filter Active Ingredients Reset all filters

6 All

01 6Encorafenib

filter Dosage Form Reset all filters

6 All

01 2Capsule

02 4Hard Capsule

filter Country Reset all filters

6 All

01 2Spain

02 2Sweden

03 2Switzerland

filter Brand Name Reset all filters

6 All

01 6Braftovi

List of Suppliers

Product Main Page

01

Pierre Fabre Medicament

FNCE

Not Confirmed

Pierre Fabre Medicament

FNCE

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Approved

Registration Country : Sweden

Encorafenib

Brand Name : Braftovi

Dosage Form : Capsule

Dosage Strength : 50mg

Packaging :

Approval Date : 20/09/2018

Application Number : 20170731000076

Regulatory Info : Approved

Registration Country : Sweden

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

Pierre Fabre Medicament

FNCE

Not Confirmed

Pierre Fabre Medicament

FNCE

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Approved

Registration Country : Sweden

Encorafenib

Brand Name : Braftovi

Dosage Form : Capsule

Dosage Strength : 75mg

Packaging :

Approval Date : 20/09/2018

Application Number : 20170731000083

Regulatory Info : Approved

Registration Country : Sweden

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

Pierre Fabre Pharma Sa

FNCE

Not Confirmed

Pierre Fabre Pharma Sa

FNCE

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Allowed

Registration Country : Switzerland

Encorafenib

Brand Name : Braftovi

Dosage Form : Hard Capsule

Dosage Strength : 50mg

Packaging :

Approval Date : 01/11/2019

Application Number : 66795

Regulatory Info : Allowed

Registration Country : Switzerland

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

Pierre Fabre Pharma Sa

FNCE

Not Confirmed

Pierre Fabre Pharma Sa

FNCE

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Allowed

Registration Country : Switzerland

Encorafenib

Brand Name : Braftovi

Dosage Form : Hard Capsule

Dosage Strength : 75mg

Packaging :

Approval Date : 01/11/2019

Application Number : 66795

Regulatory Info : Allowed

Registration Country : Switzerland

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

Pierre Fabre Medicament

FNCE

Not Confirmed

Pierre Fabre Medicament

FNCE

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Authorized

Registration Country : Spain

Encorafenib

Brand Name : Braftovi

Dosage Form : Hard Capsule

Dosage Strength : 50MG

Packaging :

Approval Date : 2018-10-04

Application Number : 1181314001

Regulatory Info : Authorized

Registration Country : Spain

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

06

Pierre Fabre Medicament

FNCE

Not Confirmed

Pierre Fabre Medicament

FNCE

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Authorized

Registration Country : Spain

Encorafenib

Brand Name : Braftovi

Dosage Form : Hard Capsule

Dosage Strength : 75MG

Packaging :

Approval Date : 2018-10-04

Application Number : 1181314002

Regulatory Info : Authorized

Registration Country : Spain

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!